FDA authorizes Quidel QuickVue At-Home COVID-19 test

Create PDF

Based on the interim results of a clinical study where the test was compared with an FDA-authorized molecular SARS-CoV-2 test, the QuickVue At-Home COVID-19 test correctly identified 84.8 percent of positive specimens and 99.1 percent of negative specimens.